Institut Pasteur de Lille Fondation

Institut Pasteur de Lille Fondation is a research organisation in Lille, France that has taken part in 21 EU-funded projects since 2008, receiving €10.4M in EU funding and leading 1 as coordinator.

EU funding received€10.4M
EU projects21
As coordinator1
Running now5
First EU project2008
Latest project2025
CountryFrance
EU registration (PIC)999498089
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Pasteur de Lille Fondation's own share of each project, not the project's full budget.

  • Horizon 2020€5.0M · 6 projects
  • FP7 (2007 to 2013)€2.8M · 11 projects
  • Horizon Europe€2.7M · 3 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

21 EU-funded projects, newest first. Institut Pasteur de Lille Fondation led 1 of them as coordinator. Each links to the official record.

  • FACTORSPartner

    Biological Factors in Fleas: Determinants of Physiology and Pathogen Transmission

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €91ktheir share
  • NeurotechEUAssociated partner

    European University of Brain and Technology

    Erasmus+ (ERASMUS+) · 2023–2027 · Project on the EU portal ↗

  • NOSEVACPartner

    INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TRACT

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.1Mtheir share
  • TBVAC-HORIZONPartner

    Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €491ktheir share
  • FAIRAssociated partner

    FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • ERA4TBPartner

    EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €3.3Mtheir share
  • ImmunoBileAssociated partner

    Bile acid, immune-metabolism, lipid and glucose homeostasis

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

  • PERISCOPEPartner

    PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €800ktheir share
  • CoSTREAMPartner

    Common mechanisms and pathways in Stroke and Alzheimer's disease.

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €325ktheir share
  • TBVAC2020Partner

    TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €538ktheir share
  • NANOREGPartner

    A common European approach to the regulatory testing of nanomaterials

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €18ktheir share
  • AGEDBRAINSYSBIOPartner

    SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €300ktheir share
  • RESOLVEPartner

    A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €772ktheir share
  • BIOMARCAREPartner

    Biomarker for Cardiovascular Risk Assessment in Europe

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €54ktheir share
  • HAIFREEPartner

    A Novel Filtration Technology Targeted at Enhancing the European Healthcare System´s Efforts in Restraining the Spread of the Hospital Infection

    FP7 (2007 to 2013) · 2011–2012 · Project on CORDIS ↗

    €8ktheir share
  • THESCHISTOVACPartner

    The targeted development of a new generation Vaccine for Schistosomiasis

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €363ktheir share
  • NEWTBVACPartner

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €380ktheir share
  • P16 AND METABOLISMCoordinator

    The role of p16INK4a in the development of obesity and insulin resistance

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €164ktheir share
  • TB PAN-NETPartner

    Pan-European network for the study and clinical management of drug resistant tuberculosis

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €212ktheir share
  • HOMITBPartner

    Host and microbial molecular dissection of pathogenesis and immunity in tuberculosis

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €310ktheir share
  • TOBIPartner

    Targeting OBesity-driven Inflammation

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €239ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alzheimer
  • antibiotics
  • artificial intelligence
  • cardiovascular diseases
  • coronaviruses
  • crisis management
  • diabetes
  • drug discovery
  • drug resistance
  • ecosystems
  • epidemiology
  • genomes
  • health care services
  • hepatology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime